Literature DB >> 26408415

Kallikreins - The melting pot of activity and function.

Magdalena Kalinska1, Ulf Meyer-Hoffert2, Tomasz Kantyka3, Jan Potempa4.   

Abstract

The human tissue kallikrein and kallikrein-related peptidases (KLKs), encoded by the largest contiguous cluster of protease genes in the human genome, are secreted serine proteases with diverse expression patterns and physiological roles. Because of the broad spectrum of processes that are modulated by kallikreins, these proteases are the subject of extensive investigations. This review brings together basic information about the biochemical properties affecting enzymatic activity, with highlights on post-translational modifications, especially glycosylation. Additionally, we present the current state of knowledge regarding the physiological functions of KLKs in major human organs and outline recent discoveries pertinent to the involvement of kallikreins in cell signaling and in viral infections. Despite the current depth of knowledge of these enzymes, many questions regarding the roles of kallikreins in health and disease remain unanswered.
Copyright © 2015 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  EGF; Enzymatic activity; Glycosylation; Kallikrein; PSA; Serine proteases

Mesh:

Substances:

Year:  2015        PMID: 26408415      PMCID: PMC4747678          DOI: 10.1016/j.biochi.2015.09.023

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  173 in total

1.  Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease.

Authors:  K Ogawa; T Yamada; Y Tsujioka; J Taguchi; M Takahashi; Y Tsuboi; Y Fujino; M Nakajima; T Yamamoto; H Akatsu; S Mitsui; N Yamaguchi
Journal:  Psychiatry Clin Neurosci       Date:  2000-08       Impact factor: 5.188

2.  TSG-6 potentiates the antitissue kallikrein activity of inter-alpha-inhibitor through bikunin release.

Authors:  Rosanna Forteza; Susana M Casalino-Matsuda; Maria Elena Monzon; Erik Fries; Marilyn S Rugg; Caroline M Milner; Anthony J Day
Journal:  Am J Respir Cell Mol Biol       Date:  2006-07-27       Impact factor: 6.914

3.  Substrate specificity of kallikrein-related peptidase 13 activated by salts or glycosaminoglycans and a search for natural substrate candidates.

Authors:  Douglas Andrade; Diego M Assis; Jorge A N Santos; Fabiana M Alves; Izaura Y Hirata; Mariana S Araujo; Sachiko I Blaber; Michael Blaber; Maria A Juliano; Luiz Juliano
Journal:  Biochimie       Date:  2011-06-12       Impact factor: 4.079

4.  Clinical significance of kallikrein-related peptidase-4 in oral cancer.

Authors:  Petros Papagerakis; Giuseppe Pannone; L I Zheng; Maria Athanassiou-Papaefthymiou; Yashuo Yamakoshi; Howard Stan McGuff; Omar Shkeir; Konstantinos Ghirtis; Silvana Papagerakis
Journal:  Anticancer Res       Date:  2015-04       Impact factor: 2.480

5.  Kallikrein-related peptidase 6 in Alzheimer's disease and vascular dementia.

Authors:  Emma L Ashby; Patrick G Kehoe; Seth Love
Journal:  Brain Res       Date:  2010-09-21       Impact factor: 3.252

6.  Epidermal growth factor system regulates mucin production in airways.

Authors:  K Takeyama; K Dabbagh; H M Lee; C Agustí; J A Lausier; I F Ueki; K M Grattan; J A Nadel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

7.  Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6.

Authors:  Tomasz Kantyka; Jan Fischer; Zhihong Wu; Wim Declercq; Karina Reiss; Jens-Michael Schröder; Ulf Meyer-Hoffert
Journal:  Peptides       Date:  2011-03-23       Impact factor: 3.750

8.  Human kallikrein 10: a novel tumor marker for ovarian carcinoma?

Authors:  L Y Luo; P Bunting; A Scorilas; E P Diamandis
Journal:  Clin Chim Acta       Date:  2001-04       Impact factor: 3.786

Review 9.  Targeting kallikrein-related peptidases in prostate cancer.

Authors:  Konstantinos Mavridis; Margaritis Avgeris; Andreas Scorilas
Journal:  Expert Opin Ther Targets       Date:  2014-02-27       Impact factor: 6.902

10.  Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.

Authors:  George M Yousef; Andreas Scorilas; Dionyssios Katsaros; Stefano Fracchioli; Lisa Iskander; Carla Borgono; Irene A Rigault de la Longrais; Manuela Puopolo; Marco Massobrio; Eleftherios P Diamandis
Journal:  J Clin Oncol       Date:  2003-08-15       Impact factor: 44.544

View more
  26 in total

1.  Gingipains of Porphyromonas gingivalis Affect the Stability and Function of Serine Protease Inhibitor of Kazal-type 6 (SPINK6), a Tissue Inhibitor of Human Kallikreins.

Authors:  Karolina Plaza; Magdalena Kalinska; Oliwia Bochenska; Ulf Meyer-Hoffert; Zhihong Wu; Jan Fischer; Katherine Falkowski; Laura Sasiadek; Ewa Bielecka; Barbara Potempa; Andrzej Kozik; Jan Potempa; Tomasz Kantyka
Journal:  J Biol Chem       Date:  2016-06-27       Impact factor: 5.157

Review 2.  The role of the prostate in male fertility, health and disease.

Authors:  Paolo Verze; Tommaso Cai; Stefano Lorenzetti
Journal:  Nat Rev Urol       Date:  2016-06-01       Impact factor: 14.432

3.  Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influenza B Virus for Replication in Human Airways.

Authors:  Manon Laporte; Annelies Stevaert; Valerie Raeymaekers; Talitha Boogaerts; Inga Nehlmeier; Winston Chiu; Mohammed Benkheil; Bart Vanaudenaerde; Stefan Pöhlmann; Lieve Naesens
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

Review 4.  Eosinophilic esophagitis: Immune mechanisms and therapeutic targets.

Authors:  Dilawar Khokhar; Sahiti Marella; Gila Idelman; Joy W Chang; Mirna Chehade; Simon P Hogan
Journal:  Clin Exp Allergy       Date:  2022-07-19       Impact factor: 5.401

5.  Upregulation of p53 through induction of MDM2 degradation: Amino acid prodrugs of anthraquinone analogs.

Authors:  Abiodun Anifowose; Zhengnan Yuan; Xiaoxiao Yang; Zhixiang Pan; Yueqin Zheng; Zhongwei Zhang; Binghe Wang
Journal:  Bioorg Med Chem Lett       Date:  2019-11-11       Impact factor: 2.823

6.  Kallikrein-Related Peptidase mRNA Expression in Adenoid Cystic Carcinoma of Salivary Glands: A Polymerase Chain Reaction Study.

Authors:  Zachary Kerr; Alyssa Hayter; Zia Khan; Mark Darling
Journal:  Head Neck Pathol       Date:  2019-09-12

Review 7.  Remodelling of the tumour microenvironment by the kallikrein-related peptidases.

Authors:  Srilakshmi Srinivasan; Thomas Kryza; Jyotsna Batra; Judith Clements
Journal:  Nat Rev Cancer       Date:  2022-01-31       Impact factor: 69.800

Review 8.  Effects of Glycosylation on the Enzymatic Activity and Mechanisms of Proteases.

Authors:  Peter Goettig
Journal:  Int J Mol Sci       Date:  2016-11-25       Impact factor: 5.923

9.  The solution structure of the kallikrein-related peptidases inhibitor SPINK6.

Authors:  Sascha Jung; Jan Fischer; Björn Spudy; Tim Kerkow; Frank D Sönnichsen; Li Xue; Alexandre M J J Bonvin; Peter Goettig; Viktor Magdolen; Ulf Meyer-Hoffert; Joachim Grötzinger
Journal:  Biochem Biophys Res Commun       Date:  2016-01-30       Impact factor: 3.575

10.  Structural studies of complexes of kallikrein 4 with wild-type and mutated forms of the Kunitz-type inhibitor BbKI.

Authors:  Mi Li; Jaroslav Srp; Michael Mareš; Alexander Wlodawer; Alla Gustchina
Journal:  Acta Crystallogr D Struct Biol       Date:  2021-07-29       Impact factor: 5.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.